SCHEMBL19225348

SCHEMBL19225348

CCc1nnc(Cc2ccc(F)c(F)c2F)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
RIPK1 Q13546 1/20 0.33
RAB9A P51151 5/20 0.32
NPC1 O15118 4/20 0.32
P2RX7 Q99572 2/20 0.32
POLB P06746 3/20 0.32
ATM Q13315 1/20 0.31
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TSHR P16473 2/20 0.31
LMNA P02545 1/20 0.31
ALOX15 P16050 1/20 0.31
OPRK1 P41145 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20724194 0.87 ALDH1A1 (0.40) ALDH1A1GRIN1GRIN2BRAB9ANPC1
SCHEMBL19157476 0.83 GRIN2B (0.37) ALDH1A1GRIN1GRIN2BRAB9ANPC1
SCHEMBL20340996 0.83 MEP1B (0.39) ALDH1A1GRIN1GRIN2BRAB9ANPC1
SCHEMBL19220564 0.80 GLA (0.33) ALDH1A1RAB9ANPC1P2RX7KDM4E
SCHEMBL19225380 0.79 ALDH1A1 (0.31) ALDH1A1
SCHEMBL19157898 0.79 IDO1 (0.42) ALDH1A1GRIN1GRIN2BRIPK1RAB9A
SCHEMBL18542002 0.79 MEN1 (0.38) ALDH1A1GRIN1GRIN2BRIPK1RAB9A
SCHEMBL20724196 0.76 MPO (0.38) ALDH1A1RAB9ANPC1P2RX7POLB
SCHEMBL20724171 0.76 DPP4 (0.33) ALDH1A1GRIN1GRIN2BRAB9ANPC1
SCHEMBL20340997 0.73 KMT2A (0.39) ALDH1A1RAB9ANPC1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202404-B2 Polycyclic pyridone derivative having integrase inhibitory activity SHIONOGI & CO., LTD. (JP) 2019-02-12 US disclosed
US-20170226128-A1 POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226128-A1 POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY TYMP, CDK6, IMPA1 ALDH1A1 1332/4885GRIN1 3337/4885GRIN2B 3998/4885
US-10202404-B2 Polycyclic pyridone derivative having integrase inhibitory activity TYMP, CDK6, IMPA1 ALDH1A1 1332/4885GRIN1 3337/4885GRIN2B 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.